×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABT – abbott laboratories (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
11:42 am
abt
Abbott (ABT): Assessing Valuation After New Regulatory Wins for Its Pediatric Heart Device Innovation [Yahoo! Finance]
Low
Report
Abbott (ABT): Assessing Valuation After New Regulatory Wins for Its Pediatric Heart Device Innovation [Yahoo! Finance]
12/18
09:39 am
abt
Can Abbott Laboratories (ABT) Deliver Resilient Returns in the Long Term? [Yahoo! Finance]
Low
Report
Can Abbott Laboratories (ABT) Deliver Resilient Returns in the Long Term? [Yahoo! Finance]
12/18
09:34 am
abt
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart [Yahoo! Finance]
Low
Report
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart [Yahoo! Finance]
12/18
09:00 am
abt
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
Low
Report
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
12/17
07:03 pm
abt
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? [Yahoo! Finance]
Low
Report
Is Trending Stock Abbott Laboratories (ABT) a Buy Now? [Yahoo! Finance]
12/17
06:19 am
abt
Abbott Laboratories (NYSE:ABT) Shareholders Will Want The ROCE Trajectory To Continue [Yahoo! Finance]
Low
Report
Abbott Laboratories (NYSE:ABT) Shareholders Will Want The ROCE Trajectory To Continue [Yahoo! Finance]
12/17
04:52 am
abt
Blood Glucose Monitor Market Set to Reach USD 25.4 Billion by 2030 with a CAGR of 9.1% [Yahoo! Finance]
Low
Report
Blood Glucose Monitor Market Set to Reach USD 25.4 Billion by 2030 with a CAGR of 9.1% [Yahoo! Finance]
12/15
10:31 pm
abt
??????????????????????????????????????(CAGR)4.2%??????2033????37?????????????????????? [CNET News]
Low
Report
??????????????????????????????????????(CAGR)4.2%??????2033????37?????????????????????? [CNET News]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/12
05:04 pm
abt
Form 4 ABBOTT LABORATORIES For: Dec 11 Filed by: Salvadori Daniel Gesua Sive
Low
Report
Form 4 ABBOTT LABORATORIES For: Dec 11 Filed by: Salvadori Daniel Gesua Sive
12/12
04:11 pm
abt
Form 8-K ABBOTT LABORATORIES For: Dec 12
Low
Report
Form 8-K ABBOTT LABORATORIES For: Dec 12
12/3
11:02 am
abt
Form SCHEDULE 13G/A ABBOTT LABORATORIES Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A ABBOTT LABORATORIES Filed by: VANGUARD GROUP INC
11/25
04:18 pm
abt
Form 4 ABBOTT LABORATORIES For: Nov 25 Filed by: Shroff Eric
Low
Report
Form 4 ABBOTT LABORATORIES For: Nov 25 Filed by: Shroff Eric
11/25
04:09 pm
abt
Form 144 ABBOTT LABORATORIES Filed by: Shroff Eric
Low
Report
Form 144 ABBOTT LABORATORIES Filed by: Shroff Eric
11/21
04:06 pm
abt
Form 8-K ABBOTT LABORATORIES For: Nov 18
Low
Report
Form 8-K ABBOTT LABORATORIES For: Nov 18
11/20
07:38 am
abt
Form 8-K ABBOTT LABORATORIES For: Nov 19
Low
Report
Form 8-K ABBOTT LABORATORIES For: Nov 19
10/29
04:23 pm
abt
Form 10-Q ABBOTT LABORATORIES For: Sep 30
Low
Report
Form 10-Q ABBOTT LABORATORIES For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Abbott Labs Is Sliding Closer To Attractive Territory [Seeking Alpha]
10.0%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
TOP News Decliners
3/18
Associated Press: Cancer and heart surgeries now delayed as coronavirus alters care [MarketWatch]
-10.8%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: